We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Partners With Amgen to Manufacture Potential COVID-19 Antibody
Eli Lilly Partners With Amgen to Manufacture Potential COVID-19 Antibody
Eli Lilly has entered into a global partnership with Amgen to increase supply capacity for Eli Lilly’s neutralizing antibodies as a treatment for COVID-19 patients.